Comparing music therapy and cognitive behavioral therapy for anxiety in cancer survivors
Official title: Music Therapy vs. Cognitive-Behavioral Therapy for Cancer-related Anxiety (MELODY)
Run by Memorial Sloan Kettering Cancer Center · NCT05215353 · Data updated 2026-11-12
This study tests whether music therapy or cognitive behavioral therapy helps reduce anxiety in cancer survivors who have finished treatment.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 368 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 3 sites (Miami, Florida and 2 other locations) |
| Status | Recruiting |
| Started | January 14, 2022 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT05215353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include English- or Spanish-speaking adults aged 18 and older who have a prior cancer diagnosis and experience anxiety symptoms.
✕Probably not a fit
Patients currently undergoing active cancer treatment or those with significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of music therapy and cognitive behavioral therapy (CBT) delivered virtually in reducing anxiety among cancer survivors. Researchers will also investigate how personal characteristics and cognitive factors influence participants' responses to these therapies. Participants will be randomly assigned to either the music therapy or CBT group and will undergo assessments to measure their anxiety levels. The study focuses on individuals who have completed cancer treatment and are currently free of disease or have stable disease.
Why it matters
Potential benefit: If successful, this study could provide effective non-pharmacological treatment options for anxiety in cancer survivors.
How similar studies have gone: Other studies have shown promising results in using music therapy and CBT for anxiety, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * English- or Spanish-speaking * 18 years or older * Prior cancer diagnosis of any type or stage * Free of oncological disease, or stable disease with no evidence of progression * Score of ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * Report anxiety symptoms lasting at least one month * Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MT or CBT * Access to Zoom and a quiet/private location Inclusion Criteria for Advanced Cancer Sub-Study (N=50) * English-speaking * 18 years or older * Advanced cancer diagnosis: stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or leukemia * Currently receiving oncological treatment or on active surveillance * Karnofsky performance score of ≥60 * Score of ≥8 on the HADS anxiety subscale * Anxiety symptoms lasting for at least 1 month * Greater than 6-month expected survival as judged by the treating oncologist * Willing to adhere to all study procedures * Access to Zoom and a quiet/private location Inclusion Criteria for group MT sub-study (N=18) * English-speaking * 18 years or older * Prior cancer diagnosis of any type or stage * Free of oncological disease, or stable disease with no evidence of progression * Score of ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * Report anxiety symptoms lasting at least one month * Willing to adhere to all study-related procedures * Access to Zoom and a quiet/private location Exclusion Criteria: * Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed). * Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse * Score of ≥10 indicative of cognitive impairment on the Blessed Orientation-Memory-Concentration * Received a treatment course of seven or greater MT or CBT sessions for anxiety symptoms within the last six months * Unable to provide informed consent for themselves Exclusion Criteria for Advanced Cancer Sub-Study * Active suicidal ideation; bipolar disorder, schizophrenia, or substance abuse * Score of ≥10 on Blessed Orientation-Memory-Concentration * Prior receipt of MT within the past six months * Plan to receive any form of psychotherapy in the coming 8 weeks * Initiation or change in anxiety medications within the past 4 weeks * Plan to initiate or change anxiety medications in the coming 8 weeks * Unable to provide informed consent for themselves Exclusion Criteria for group MT sub-study * Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed). * Active suicidal ideation; bipolar disorder, schizophrenia, or substance abuse * Score of ≥10 on Blessed Orientation-Memory-Concentration * Prior receipt of MT within the past six months * Plan to receive any form of psychotherapy in the coming 8 weeks * Initiation or change in anxiety medications within the past 4 weeks * Unable to provide informed consent for themselves
Where it's running
-
Baptist Alliance MCI
Miami, Florida, United States Recruiting -
Memorial Sloan Kettering Cancer Center
New York, New York, United States Recruiting -
Drexel University
Philadelphia, Pennsylvania, United States Active not recruiting
Study contacts
- Principal investigator: Jun Mao, MD, MSCE — Memorial Sloan Kettering Cancer Center
- Study coordinator: Jun Mao, MD, MSCE
- Email: maoj@mskcc.org
- Phone: 646-608-8552
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive training with real-time brain feedback for childhood medulloblastoma survivors
This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.
-
Hematologic cancer survivors after stem cell transplant try a personalized care plan
This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.
-
Support program to improve quality of life for Chinese cancer patients and survivors
This program will try different mixes of education, counseling, and peer support to see if they help Mandarin-speaking adults with cancer or who have finished treatment feel better.
-
On-Trac: Online training to manage anxiety after cancer
This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.
-
Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction
This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.
-
LiveWell: a tailored DBT skills program for people living with metastatic lung cancer
This pilot randomized trial tests a telehealth DBT skills program called LiveWell for adults with metastatic non-small cell lung cancer and distress to see if it reduces distress and improves well-being compared to usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.